GAD has significant clinical implications. Autoantibodies against GAD65 are found in patients with Type 1 diabetes, indicating an autoimmune response against pancreatic beta cells. Moreover, abnormalities in GAD expression are linked to neurological disorders such as epilepsy, schizophrenia, and stiff person syndrome.
